Cargando…

Erratum to: Echocardiography and cardiac resynchronization therapy, friends or foes?

Detalles Bibliográficos
Autores principales:	van Everdingen, W. M., Schipper, J. C., van ’t Sant, J., Misier, K. Ramdat, Meine, M., Cramer, M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771629/ https://www.ncbi.nlm.nih.gov/pubmed/26886921 http://dx.doi.org/10.1007/s12471-016-0807-9

Ejemplares similares

Echocardiography and cardiac resynchronisation therapy, friends or foes?
por: van Everdingen, W.M., et al.
Publicado: (2015)

Erratum to: The Use of Nuclear Imaging for Cardiac Resynchronization Therapy
por: Chen, Ji, et al.
Publicado: (2010)

Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome
por: van ’t Sant, Jetske, et al.
Publicado: (2015)

Septal rebound stretch as predictor of echocardiographic response to cardiac resynchronization therapy
por: Ghani, Abdul, et al.
Publicado: (2015)

Does mechanical dyssynchrony in addition to QRS area ensure sustained response to cardiac resynchronization therapy?
por: Wouters, Philippe C, et al.
Publicado: (2021)

Erratum to: Mechano-energetics of the asynchronous and resynchronized heart
por: Prinzen, Frits W., et al.
Publicado: (2011)

Multimodality imaging for real-time image-guided left ventricular lead placement during cardiac resynchronization therapy implantations
por: Salden, Odette A. E., et al.
Publicado: (2019)

Vectorcardiography for Optimization of Stimulation Intervals in Cardiac Resynchronization Therapy
por: van Deursen, Caroline J. M., et al.
Publicado: (2015)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Erratum to: ‘Modified transesophageal echocardiography of the dissected thoracic aorta; a novel diagnostic approach’
por: Jansen Klomp, Wouter W., et al.
Publicado: (2016)

Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques
por: Zweerink, Alwin, et al.
Publicado: (2018)

Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases
por: Li, Jin, et al.
Publicado: (2018)

Echocardiographic prediction of outcome after cardiac resynchronization therapy: conventional methods and recent developments
por: Leenders, Geert E., et al.
Publicado: (2010)

On-screen image-guided lead placement in cardiac resynchronization therapy: Feasibility and outcome in a multicenter setting
por: Wouters, Philippe C., et al.
Publicado: (2022)

Oxygen, the lung and the diver: friends and foes?
por: van Ooij, Pieter-Jan A.M., et al.
Publicado: (2016)

Synchronization of repolarization after cardiac resynchronization therapy: A combined clinical and modeling study
por: Verzaal, Nienke J., et al.
Publicado: (2022)

Optimisation of cardiac resynchronisation therapy during exercise
por: Ghani, A., et al.
Publicado: (2013)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Erratum to: Echocardiography for adult patients supported with extracorporeal membrane oxygenation
por: Douflé, Ghislaine, et al.
Publicado: (2016)

Erratum for Foe et al., “The Toxoplasma gondii Active Serine Hydrolase 4 Regulates Parasite Division and Intravacuolar Parasite Architecture”
por: Foe, Ian T., et al.
Publicado: (2018)

Friend and Foe
Publicado: (1890)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Erratum to Kichloo A, Solanki D, Berger R, et al. Trends in the Use and Complications of Cardiac Resynchronization Therapy Device Implantation in Chronic Kidney Disease. J Innov Cardiac Rhythm Manage. 2023;14(2):5339–5347
Publicado: (2023)

Nucleolar stress: Friend or foe in cardiac function?
por: Yan, Daliang, et al.
Publicado: (2022)

Erratum to: Measuring adolescent friendly health services in India: A scoping review of evaluations
por: Hoopes, Andrea J., et al.
Publicado: (2017)

Nicotine replacement therapy: A friend or foe
por: Devi, Rajkumari E., et al.
Publicado: (2020)

Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism
por: van der Wall, E. E., et al.
Publicado: (2010)

Lithium in Cancer Therapy: Friend or Foe?
por: Yang, Chunhao, et al.
Publicado: (2023)

Fluid Therapy from Friend to Foe
por: Fodor, Raluca
Publicado: (2023)

Glutamine supplementation in the critically ill: friend or foe?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2014)

Erratum to: Fine-grained information extraction from German transthoracic echocardiography reports
por: Toepfer, Martin, et al.
Publicado: (2015)

Corrigendum to “Cardiac resynchronization therapy in patients with mild heart failure is a reversal therapy” [Indian Heart J. 69 (1) (2017) 112–118]
por: Ali-Hasan-Al-Saegh, Sadeq, et al.
Publicado: (2017)

Oxygen: both friend and foe
por: Purvis, J
Publicado: (2018)

Statins and Cardiomyocyte Metabolism, Friend or Foe?
por: Somers, Tim, et al.
Publicado: (2023)

The Hippo pathway and cancer immunity: friend or foe?
por: Janse van Rensburg, Helena J, et al.
Publicado: (2018)

Echo response and clinical outcome in CRT patients
por: van ’t Sant, J., et al.
Publicado: (2015)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

Erratum to “Comparison of Echocardiographic and Electrocardiographic Mapping for Cardiac Resynchronisation Therapy Optimisation”
por: Pereira, Helder, et al.
Publicado: (2019)

Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study
por: Tanaka, Hidekazu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gm5euvbbjib05snt3annm1v3tv